These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 22256608

  • 1. [PolyI:C-induced neurodevelopmental animal model for schizophrenia].
    Ibi D, Nagai T, Nabeshima T, Yamada K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):201-7. PubMed ID: 22256608
    [Abstract] [Full Text] [Related]

  • 2. Animal model for schizophrenia that reflects gene-environment interactions.
    Nagai T, Ibi D, Yamada K.
    Biol Pharm Bull; 2011 Nov; 34(9):1364-8. PubMed ID: 21881218
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Perinatal innate immune activation and neuropsychological development].
    Nagai T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):149-54. PubMed ID: 25069250
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological and proteomic analyses of neonatal polyI:C-treated adult mice.
    Kitagawa K, Nagai T, Yamada K.
    Neurosci Res; 2019 Oct; 147():39-47. PubMed ID: 31446906
    [Abstract] [Full Text] [Related]

  • 7. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.
    Ibi D, Nagai T, Kitahara Y, Mizoguchi H, Koike H, Shiraki A, Takuma K, Kamei H, Noda Y, Nitta A, Nabeshima T, Yoneda Y, Yamada K.
    Neurosci Res; 2009 Jul; 64(3):297-305. PubMed ID: 19447299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.
    Piontkewitz Y, Assaf Y, Weiner I.
    Biol Psychiatry; 2009 Dec 01; 66(11):1038-46. PubMed ID: 19726031
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia.
    Meyer U, Feldon J, Schedlowski M, Yee BK.
    Neurosci Biobehav Rev; 2005 Dec 01; 29(6):913-47. PubMed ID: 15964075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1.
    O'Leary C, Desbonnet L, Clarke N, Petit E, Tighe O, Lai D, Harvey R, Waddington JL, O'Tuathaigh C.
    Neuroscience; 2014 Sep 26; 277():294-305. PubMed ID: 24969132
    [Abstract] [Full Text] [Related]

  • 18. Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition.
    Zavitsanou K, Lim CK, Purves-Tyson T, Karl T, Kassiou M, Banister SD, Guillemin GJ, Weickert CS.
    Brain Behav Immun; 2014 Oct 26; 41():173-81. PubMed ID: 24878170
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.